Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follicular vs luteal phase ovarian stimulation in suboptimal responders (SUBLUTEAL study)
2019-001342-18Phase 4Completed
- Sponsor
- Instituto Bernabeu
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of corifollitropin alfa in poor ovarian response (POR) (2 arms), sponsored by Instituto Bernabeu. Primary endpoint: Number of cumulus-oocyte complexes obtained. Started Apr 2019; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on 2019-001342-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001342-18.